GSE239844 crizotinib 8 v 0 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE239844_crizotinib_8_v_0_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE239844_crizotinib_8_v_0_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE239844_crizotinib_8_v_0_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE239844_crizotinib_8_v_0_human_up.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 5

Gene

colony stimulating factor 2 receptor subunit alpha

Gene

long intergenic non-protein coding RNA 1291

Gene

MIR1915 host gene

Gene

NBPF member 26

Gene

long intergenic non-protein coding RNA, p53 induced transcript

Gene

NmrA like redox sensor 2, pseudogene

Gene

SLC16A1 antisense RNA 1

Gene

small nucleolar RNA host gene 33

Gene

mir-99a-let-7c cluster host gene

  • Gene

    small nucleolar RNA host gene 5


  • Gene

    colony stimulating factor 2 receptor subunit alpha


  • Gene

    long intergenic non-protein coding RNA 1291




  • Gene

    long intergenic non-protein coding RNA, p53 induced transcript


  • Gene

    NmrA like redox sensor 2, pseudogene


  • Gene

    SLC16A1 antisense RNA 1


  • Gene

    small nucleolar RNA host gene 33


  • Gene

    mir-99a-let-7c cluster host gene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.